Terry L. Fox

1.9k total citations
9 papers, 1.5k citations indexed

About

Terry L. Fox is a scholar working on Epidemiology, Surgery and Dermatology. According to data from OpenAlex, Terry L. Fox has authored 9 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 3 papers in Surgery and 3 papers in Dermatology. Recurrent topics in Terry L. Fox's work include Nonmelanoma Skin Cancer Studies (5 papers), Cervical Cancer and HPV Research (4 papers) and Genital Health and Disease (3 papers). Terry L. Fox is often cited by papers focused on Nonmelanoma Skin Cancer Studies (5 papers), Cervical Cancer and HPV Research (4 papers) and Genital Health and Disease (3 papers). Terry L. Fox collaborates with scholars based in United States, Australia and United Kingdom. Terry L. Fox's co-authors include Mary Owens, Karl R. Beutner, Spotswood L. Spruance, Andrina J. Hougham, John M. Douglas, James H. Lee, John K. Geisse, Scott M. Dinehart, Joseph L. Jorizzo and Stephen Shumack and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of the American Academy of Dermatology and Sexually Transmitted Diseases.

In The Last Decade

Terry L. Fox

9 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Terry L. Fox United States 9 1.1k 666 435 335 198 9 1.5k
John K. Geisse United States 12 709 0.6× 629 0.9× 378 0.9× 245 0.7× 133 0.7× 19 1.1k
Pawel G. Fuchs Germany 24 1.6k 1.4× 366 0.5× 689 1.6× 274 0.8× 24 0.1× 36 2.3k
Baki Akgũl Germany 24 872 0.8× 221 0.3× 525 1.2× 311 0.9× 25 0.1× 77 1.7k
Andreas Kleinheinz Germany 14 1.2k 1.1× 285 0.4× 302 0.7× 381 1.1× 14 0.1× 28 1.9k
Kiyofumi Egawa Japan 15 766 0.7× 236 0.4× 224 0.5× 191 0.6× 13 0.1× 63 1.1k
Kristina M. Michael Germany 16 863 0.8× 206 0.3× 353 0.8× 178 0.5× 13 0.1× 22 1.2k
L. M. Tieben Netherlands 7 677 0.6× 363 0.5× 292 0.7× 88 0.3× 17 0.1× 9 920
Sönke Jan Weißenborn Germany 13 776 0.7× 256 0.4× 325 0.7× 164 0.5× 16 0.1× 14 984
Linda M. Imbertson United States 7 355 0.3× 135 0.2× 104 0.2× 448 1.3× 58 0.3× 7 794
T. Surentheran United Kingdom 9 692 0.6× 306 0.5× 325 0.7× 103 0.3× 12 0.1× 10 843

Countries citing papers authored by Terry L. Fox

Since Specialization
Citations

This map shows the geographic impact of Terry L. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry L. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry L. Fox more than expected).

Fields of papers citing papers by Terry L. Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry L. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry L. Fox. The network helps show where Terry L. Fox may publish in the future.

Co-authorship network of co-authors of Terry L. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Terry L. Fox. A scholar is included among the top collaborators of Terry L. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry L. Fox. Terry L. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jorizzo, Joseph L., Scott M. Dinehart, Robert Matheson, et al.. (2007). Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head. Journal of the American Academy of Dermatology. 57(2). 265–268. 97 indexed citations
2.
Lebwohl, Mark, Scott M. Dinehart, David Whiting, et al.. (2004). Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. Journal of the American Academy of Dermatology. 50(5). 714–721. 209 indexed citations
3.
Szeimies, Rolf‐Markus, Marie‐Jeanne P. Gerritsen, G. Gupta, et al.. (2004). Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. Journal of the American Academy of Dermatology. 51(4). 547–555. 147 indexed citations
4.
Sauder, Daniel N., Robert B. Skinner, Terry L. Fox, & Mary Owens. (2003). Topical Imiquimod 5% Cream as an Effective Treatment for External Genital and Perianal Warts in Different Patient Populations. Sexually Transmitted Diseases. 30(2). 124–128. 48 indexed citations
5.
Marks, Robin, et al.. (2001). Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: Results of a multicenter 6-week dose-response trial. Journal of the American Academy of Dermatology. 44(5). 807–813. 255 indexed citations
6.
Beutner, Karl R., et al.. (1999). Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. Journal of the American Academy of Dermatology. 41(6). 1002–1007. 276 indexed citations
7.
Beutner, Karl R., Spotswood L. Spruance, Andrina J. Hougham, et al.. (1998). Treatment of genital warts with an immune-response modifier (imiquimod). Journal of the American Academy of Dermatology. 38(2). 230–239. 226 indexed citations
8.
Owens, Mary, et al.. (1998). Percutaneous penetration of Aldara™ cream, 5% during the topical treatment of genital and perianal warts. Primary Care Update for OB/GYNS. 5(4). 151–151. 20 indexed citations
9.
Beutner, Karl R., Stephen K. Tyring, Kenneth F. Trofatter, et al.. (1998). Imiquimod, a Patient-Applied Immune-Response Modifier for Treatment of External Genital Warts. Antimicrobial Agents and Chemotherapy. 42(4). 789–794. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026